We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/1/2018 09:56 | Whoop. Finally lol . Took their time. | babbler | |
10/1/2018 09:56 | Just the start to 100p | mikeh30 | |
10/1/2018 09:56 | Easy bagger | turbotrader2 | |
10/1/2018 09:48 | Finally....here it goes.... | babbler | |
10/1/2018 09:10 | Bid rising on sells. #demand | mikeh30 | |
10/1/2018 08:31 | The strategic review will, imo, look at renegotiated terms for the license. As they say, the licensees are benefitting by substantially more than the Mcap of AOR so they will pull this back in line as well as exploiting other opportunities with better incomes. This will rerate significantly when they lay out their plans now the litigation is behind them. These used to trade at 1000p at the peak. Even a 10th of that is still a bagger at these levels. | mikeh30 | |
10/1/2018 08:31 | Hopefully... Just a wierd jump Friday must have been tipped somewhere.... In longer term anyway here. Or 1 quid. Whichever comes first lol | babbler | |
10/1/2018 08:27 | Bid at 44.5 and only 1000 shares available at 48 so expect a tick up | mikeh30 | |
09/1/2018 22:40 | Crack on indeed at 510p mikeh! | bones | |
09/1/2018 22:40 | Agreed parsons, the MCap is stingy to say the least. I am interested in seeing them increase turnover from the 200k level though! Seems relatively small for such an established IP that's out for licence. | bones | |
09/1/2018 20:06 | They last raised finance at 510p. Crack on at that price I say ;) | mikeh30 | |
09/1/2018 19:40 | Yes Bones a number of very interesting possibilities. I like the a) low overhead b) cash that will be increasing c) great product that has not been marketed to its full potential and d) extremely low market cap which does not take account of a,b &c all IMHO of course !!! | parsons4 | |
09/1/2018 18:30 | Mikeh, you reproduced some of the last RNS. Naturally we all like this:"A detailed strategic plan to allow AorTech to commercialise its platform technology is currently being considered and we will report to shareholders when the process is concluded"It will encompass all kinds of commercial ideas but I wonder if it will also involve raising finance (for positive reasons obviously) to facilitate the bigger ideas? Perhaps the legal settlement involved a decent cash injection? Or would it have entitled AOR to share in royalties of products developed by the defendants? We won't know the details as it is confidential although something has to show in the numbers eventually.Just a few thoughts crossing my mind. Whatever, it all looks promising and I have a nice holding here in anticipation. | bones | |
09/1/2018 17:24 | Bought some more this afternoon but had to pay 48p. There is obviously no stock about. Any big RNS will see the price take off !!! | parsons4 | |
09/1/2018 12:59 | The results for the year to 31 March 2017 the share price was implying that AorTech was likely to fail.The recent trading results should indicate to shareholders that the business is on a more stable footing and the risk of failure diminished. The cash position improved during the six months to 30 September 2017 and at the end of November 2017 had further increased to $328,000. We anticipate that the net cash position should improve further.A detailed strategic plan to allow AorTech to commercialise its platform technology is currently being considered and we will report to shareholders when the process is concluded | mikeh30 | |
09/1/2018 12:54 | """"Our licensees have generated considerable value by utilising Elast-Eon(TM). One example of this is a cardiovascular device that differs only from competing devices by having a thin Elast-Eon(TM) coating. This coating provides the device with superior properties and allows a sales price of many multiples of standard devices. The cost of materials and license fees, however, are less than 5% of the device's sales value.The value added to licensees is not only greater than licence fees payable, but the value of the licence fees to our customers is significantly more than the market capitalisation of AorTech""""This is the key to it all.There are very few genuine 5-10 baggers out there. This has the potential to be one so happy to buy, build and wait | mikeh30 | |
09/1/2018 12:47 | LOL!! I might have short arms and deep pockets!!! | k1ngkonggb | |
09/1/2018 12:42 | That’s assuming it’s not your round! | semper vigilans | |
09/1/2018 12:39 | The only way this will move will be contracts, and when it does, it will move faster than me getting to the bar!!!!! | k1ngkonggb | |
09/1/2018 12:24 | Wonder what made it move last week . Secret Twitter group probably. Very strange. | babbler | |
09/1/2018 09:47 | The last time I owned this shares was during the tech boom,lets hope I have better luck this time. | hibberts | |
08/1/2018 12:55 | Looking for over 100p. I'm a buyer | mikeh30 | |
08/1/2018 12:10 | The buying on Friday was mainly in the afternoon - I'm wondering if the interest's in the US? | verulamium | |
08/1/2018 12:05 | Strange considering Fridays rise... Well will buy more then thanks. | babbler | |
08/1/2018 09:17 | It was obviously a sale !!!! | parsons4 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions